The Effect of Position on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome
NCT ID: NCT00821314
Last Updated: 2010-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Incontinence, increased urge and increased frequency of micturition affect nearly 100 million people in the western world (33 million in the US and 66 million in the European Union). These conditions are not life threatening but they seriously affect quality of life and ability to work. OAB is in some studies reported to have an incidence of up to 17 % in the western population with great consequences for the quality of life.
Economic cost The total economic cost of this group of conditions is high. In 2002 the costs in the US were approximately $12.7 billion\[1\] (estimated to be $17 billion and €22 billion/year in 2005). Approximately 25% of this expenditure is spent on treatment (drug therapy, clinical consultation and surgery). Of those who suffer only 28% have sought help and only half of those currently receive treatment. Less than 3% regain long lasting normal control. Therefore, these costs are an under-estimate and the problem is large.
Aetiology
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-Micturation Bladder Activity in Relation to Self-Consciousness During Filling Phase and Sensation Measurement During the Filling Phase
NCT00628615
Brain Areas Involved in Bladder Filling and Contraction
NCT02477241
Does Position Influence the Diagnosis of Detrusor Overactivity in a Neurological Population
NCT05949567
Urodynamics: Prone Vs. Seated Position
NCT06864117
Long-term Urodynamics in Individuals With Neurogenic Lower Urinary Tract Dysfunction
NCT02443870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Because patients with pelvic floor dysfunction have widely varying expectations from treatment, the patient's goal for treatment is highly subjective. Therefore, strategies for assessing OAB should incorporate self-perceived disease condition.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients should have at least one episode of urge.
Exclusion Criteria
* Patients with a post voiding residual volume of more than 100 cc.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Head of the Urology department University Hospital Maastricht, The Netherlands
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohammad S Rahnama'i', MD
Role: PRINCIPAL_INVESTIGATOR
University hospital Maasticht
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University Hospital
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MEC 08-2-128.3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.